WORLDBiocon, Viatris Receive EC Nod For Biosimilar BevacizumabadminApril 26, 2021April 26, 2021 April 26, 2021April 26, 2021 Biocon Biologics Ltd, a subsidiary of Bengaluru-headquartered Biocon Ltd, has announced that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc.,...